Moreover, Klotho improve cellular inflammation by inhibiting cytokine release and upregulating miR-29a (36), suggesting that Klotho and the antiretroviral drug D4T may have beneficial therapeutic potential for attenuating neuroinflammation in AD. This evidence concerns the gene KL and Alzheimer disease.